-- Marshall Fordyce, Director, President, and CEO, on April 14, 2026, sold 22,951 shares in Vera Therapeutics (VERA) for $1,011,051. Following the Form 4 filing with the SEC, Fordyce has control over a total of 457,274 Class A common shares of the company, with 235,244 shares held directly and 222,030 controlled indirectly.
SEC Filing: